Lexeo Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
/ 
Frequently asked questions
To buy Lexeo Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Lexeo Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Lexeo Therapeutics Inc. is LXEO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Lexeo Therapeutics Inc. has its primary listing on NASDAQ. You can trade Lexeo Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Lexeo Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Lexeo Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Lexeo Therapeutics Inc..